|
1
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar
|
|
2
|
Li D, Xie K, Wolff R and Abbruzzese JL:
Pancreatic cancer. Lancet. 363:1049–1057. 2004. View Article : Google Scholar
|
|
3
|
Brand RE and Matamoros A: Imaging
techniques in the evaluation of adenocarcinoma of the pancreas. Dig
Dis. 16:242–252. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Goonetilleke KS and Siriwardena AK:
Systematic review of carbohydrate antigen (CA 19–9) as a
biochemical marker in the diagnosis of pancreatic cancer. Eur J
Surg Oncol. 33:266–270. 2007.PubMed/NCBI
|
|
5
|
Kawai S, Suzuki K, Nishio K, et al:
Smoking and serum CA19–9 levels according to Lewis and secretor
genotypes. Int J Cancer. 123:2880–2884. 2008.
|
|
6
|
Koopmann J, Rosenzweig CN, Zhang Z, et al:
Serum markers in patients with resectable pancreatic
adenocarcinoma: macrophage inhibitory cytokine 1 versus CA19–9.
Clin Cancer Res. 12:442–446. 2006.PubMed/NCBI
|
|
7
|
Bünger S, Laubert T, Roblick UJ and
Habermann JK: Serum biomarkers for improved diagnostic of
pancreatic cancer: a current overview. J Cancer Res Clin Oncol.
137:375–389. 2011.PubMed/NCBI
|
|
8
|
Cortez MA, Welsh JW and Calin GA:
Circulating microRNAs as noninvasive biomarkers in breast cancer.
Recent Results Cancer Res. 195:151–161. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Redova M, Poprach A, Nekvindova J, et al:
Circulating miR-378 and miR-451 in serum are potential biomarkers
for renal cell carcinoma. J Transl Med. 10:552012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jung DE, Wen J, Oh T and Song SY:
Differentially expressed microRNAs in pancreatic cancer stem cells.
Pancreas. 40:1180–1187. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Keller A, Leidinger P, Gislefoss R, et al:
Stable serum miRNA profiles as potential tool for non-invasive lung
cancer diagnosis. RNA Biol. 8:506–516. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mitchell PS, Parkin RK, Kroh EM, et al:
Circulating microRNAs as stable blood-based markers for cancer
detection. Proc Natl Acad Sci USA. 105:10513–10518. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mees ST, Mardin WA, Wendel C, et al: EP300
- a miRNA-regulated metastasis suppressor gene in ductal
adenocarcinomas of the pancreas. Int J Cancer. 126:114–124. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang J, Chen J, Chang P, et al: MicroRNAs
in plasma of pancreatic ductal adenocarcinoma patients as novel
blood-based biomarkers of disease. Cancer Prev Res. 2:807–813.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Valadi H, Ekström K, Bossios A, Sjöstrand
M, Lee JJ and Lötvall JO: Exosome-mediated transfer of mRNAs and
microRNAs is a novel mechanism of genetic exchange between cells.
Nat Cell Biol. 9:654–659. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rabinowits G, Gercel-Taylor C, Day JM,
Taylor DD and Kloecker GH: Exosomal microRNA: a diagnostic marker
for lung cancer. Clin Lung Cancer. 10:42–46. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kosaka N, Iguchi H, Yoshioka Y, Takeshita
F, Matsuki Y and Ochiya T: Secretory mechanisms and intercellular
transfer of microRNAs in living cells. J Biol Chem.
285:17442–17452. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Song B, Wang Y, Kudo K, Gavin EJ, Xi Y and
Ju J: miR-192 regulates dihydrofolate reductase and cellular
proliferation through the p53-microRNA circuit. Clin Cancer Res.
14:8080–8086. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Feng S, Cong S, Zhang X, et al:
MicroRNA-192 targeting retinoblastoma 1 inhibits cell proliferation
and induces cell apoptosis in lung cancer cells. Nucleic Acids Res.
39:6669–6678. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Vermeulen K, Van Bockstaele DR and
Berneman ZN: The cell cycle: a review of regulation, deregulation
and therapeutic targets in cancer. Cell Prolif. 36:131–149. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Classon M, Salama S, Gorka C, Mulloy R,
Braun P and Harlow E: Combinatorial roles for pRB, p107, and p130
in E2F-mediated cell cycle control. Proc Natl Acad Sci USA.
97:10820–10825. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Frescas D and Pagano M: Deregulated
proteolysis by the F-box proteins SKP2 and beta-TrCP: tipping the
scales of cancer. Nat Rev Cancer. 8:438–449. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Braun CJ, Zhang X, Savelyeva I, et al:
p53-Responsive microRNAs 192 and 215 are capable of inducing cell
cycle arrest. Cancer Res. 68:10094–10104. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cloonan N, Brown MK, Steptoe AL, et al:
The miR-17–5p microRNA is a key regulator of the G1/S phase cell
cycle transition. Genome Biol. 9:R1272008.
|
|
25
|
Lim LP, Lau NC, Garrett-Engele P, et al:
Microarray analysis shows that some microRNAs downregulate large
numbers of target mRNAs. Nature. 433:769–773. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Georges SA, Biery MC, Kim SY, et al:
Coordinated regulation of cell cycle transcripts by p53-inducible
microRNAs, miR-192 and miR-215. Cancer Res. 68:10105–10112. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang S, Hao J, Xie F, et al:
Downregulation of miR-132 by promoter methylation contributes to
pancreatic cancer development. Carcinogenesis. 32:1183–1189. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Katoh M and Katoh M: Integrative genomic
analyses of ZEB2: Transcriptional regulation of ZEB2 based on
SMADs, ETS1, HIF1α, POU/OCT, and NF-κB. Int J Oncol. 34:1737–1742.
2009.PubMed/NCBI
|
|
29
|
Mejlvang J, Kriajevska M, Vandewalle C, et
al: Direct repression of cyclin D1 by SIP1 attenuates cell cycle
progression in cells undergoing an epithelial mesenchymal
transition. Mol Biol Cell. 18:4615–4624. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sayan AE, Griffiths TR, Pal R, et al: SIP1
protein protects cells from DNA damage-induced apoptosis and has
independent prognostic value in bladder cancer. Proc Natl Acad Sci
USA. 106:14884–14889. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Grzesiak JJ and Bouvet M: The alpha2beta1
integrin mediates the malignant phenotype on type I collagen in
pancreatic cancer cell lines. Br J Cancer. 94:1311–1319. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Menke A, Philippi C, Vogelmann R, et al:
Down-regulation of E-cadherin gene expression by collagen type I
and type III in pancreatic cancer cell lines. Cancer Res.
61:3508–3517. 2001.PubMed/NCBI
|
|
33
|
Imamichi Y, König A, Gress T and Menke A:
Collagen type I-induced Smad-interacting protein 1 expression
downregulates E-cadherin in pancreatic cancer. Oncogene.
26:2381–2385. 2007. View Article : Google Scholar : PubMed/NCBI
|
